Bioxyne Ltd
ASX:BXN
| US |
|
Johnson & Johnson
NYSE:JNJ
|
Pharmaceuticals
|
| US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
Financial Services
|
| US |
|
Bank of America Corp
NYSE:BAC
|
Banking
|
| US |
|
Mastercard Inc
NYSE:MA
|
Technology
|
| US |
|
UnitedHealth Group Inc
NYSE:UNH
|
Health Care
|
| US |
|
Exxon Mobil Corp
NYSE:XOM
|
Energy
|
| US |
|
Pfizer Inc
NYSE:PFE
|
Pharmaceuticals
|
| US |
|
Palantir Technologies Inc
NYSE:PLTR
|
Technology
|
| US |
|
Nike Inc
NYSE:NKE
|
Textiles, Apparel & Luxury Goods
|
| US |
|
Visa Inc
NYSE:V
|
Technology
|
| CN |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
Retail
|
| US |
|
3M Co
NYSE:MMM
|
Industrial Conglomerates
|
| US |
|
JPMorgan Chase & Co
NYSE:JPM
|
Banking
|
| US |
|
Coca-Cola Co
NYSE:KO
|
Beverages
|
| US |
|
Walmart Inc
NYSE:WMT
|
Retail
|
| US |
|
Verizon Communications Inc
NYSE:VZ
|
Telecommunication
|
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
0.005
0.026
|
| Price Target |
|
We'll email you a reminder when the closing price reaches AUD.
Choose the stock you wish to monitor with a price alert.
|
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
|
Bank of America Corp
NYSE:BAC
|
US |
|
|
Mastercard Inc
NYSE:MA
|
US |
|
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
|
Pfizer Inc
NYSE:PFE
|
US |
|
|
Palantir Technologies Inc
NYSE:PLTR
|
US |
|
|
Nike Inc
NYSE:NKE
|
US |
|
|
Visa Inc
NYSE:V
|
US |
|
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
|
3M Co
NYSE:MMM
|
US |
|
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
|
Coca-Cola Co
NYSE:KO
|
US |
|
|
Walmart Inc
NYSE:WMT
|
US |
|
|
Verizon Communications Inc
NYSE:VZ
|
US |
This alert will be permanently deleted.
Bioxyne Ltd
Bioxyne Ltd
Other Current Assets
Bioxyne Ltd
Other Current Assets Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Other Current Assets | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Bioxyne Ltd
ASX:BXN
|
Other Current Assets
AU$892.1k
|
CAGR 3-Years
72%
|
CAGR 5-Years
28%
|
CAGR 10-Years
N/A
|
|
|
McPherson's Ltd
ASX:MCP
|
Other Current Assets
AU$821k
|
CAGR 3-Years
272%
|
CAGR 5-Years
1%
|
CAGR 10-Years
-34%
|
|
|
Star Combo Pharma Ltd
ASX:S66
|
Other Current Assets
AU$173.5k
|
CAGR 3-Years
3%
|
CAGR 5-Years
-13%
|
CAGR 10-Years
N/A
|
|
|
Elixinol Wellness Ltd
ASX:EXL
|
Other Current Assets
AU$2.1m
|
CAGR 3-Years
29%
|
CAGR 5-Years
-10%
|
CAGR 10-Years
N/A
|
|
|
B
|
Biome Australia Ltd
ASX:BIO
|
Other Current Assets
AU$81.4k
|
CAGR 3-Years
49%
|
CAGR 5-Years
14%
|
CAGR 10-Years
N/A
|
|
|
H
|
Hydration Pharmaceuticals Co Ltd
ASX:HPC
|
Other Current Assets
$710.5k
|
CAGR 3-Years
19%
|
CAGR 5-Years
41%
|
CAGR 10-Years
N/A
|
|
Bioxyne Ltd
Glance View
Bioxyne Ltd. engages in the research, development, market and distribution of health products. The company is headquartered in Sydney, New South Wales. The company went IPO on 2000-12-14. The firm is engaged in the development of, manufacture, marketing and distribution of consumer dietary supplements based on the probiotic strain of Lactobacillus Fermentum PCC. The firm operates through two segments wholesale sales and direct sales. The firm manufactures, market, supplies and distributes its probiotic strain for over the counter dietary supplement products for the food, health, pharmaceutical and agricultural businesses. The firm is focusing on developing a range of functional food and beauty products.
See Also
What is Bioxyne Ltd's Other Current Assets?
Other Current Assets
892.1k
AUD
Based on the financial report for Jun 30, 2024, Bioxyne Ltd's Other Current Assets amounts to 892.1k AUD.
What is Bioxyne Ltd's Other Current Assets growth rate?
Other Current Assets CAGR 5Y
28%
Over the last year, the Other Current Assets growth was 239%. The average annual Other Current Assets growth rates for Bioxyne Ltd have been 72% over the past three years , 28% over the past five years .
You don't have any saved screeners yet